Stephanie Ferreira1, Ruben Fernandes1,2, Monica C Botelho2,3. 1. Escola Superior de Saúde, Instituto Politécnico do Porto, Portugal. 2. I3S, Instituto de Investigação e Inovação da Universidade do Porto, Portugal. 3. INSA, National Institute of Health Dr. Ricardo Jorge, Department of Health Promotion and Chronic Diseases, Rua Alexandre Herculano, 321, 4000-055 Porto, Portugal.
Abstract
BACKGROUND: Fascioliasis is a neglected tropical disease that affects poor people from poor and developing countries. In the world, it has been estimated that at least 2.6 million people are affected with this disease. The International agency for Research on Cancer, states that O. viverrini and C. sinensis, also liver flukes, are considered as definitive causes of cholangiocarcinoma. However, fascioliasis caused by F. hepatica has not been associated with cancer to date. There are not any known causative associations between this parasite and liver cancer (cholangiocarcinoma). METHODS: Chine Hamster Ovary (CHO) cells were treated with F. hepatica extracts and cell proliferation was assessed by using the indirect method for estimating cell number based on the mitochondrial activity with MTS cell proliferation reagent. We observed unexpected death of these cells when treated with F. hepatica extracts. RESULTS: We now hypothesize that this parasite could be used as a medically-important trematode pathogen in cancer therapy.
BACKGROUND: Fascioliasis is a neglected tropical disease that affects poor people from poor and developing countries. In the world, it has been estimated that at least 2.6 million people are affected with this disease. The International agency for Research on Cancer, states that O. viverrini and C. sinensis, also liver flukes, are considered as definitive causes of cholangiocarcinoma. However, fascioliasis caused by F. hepatica has not been associated with cancer to date. There are not any known causative associations between this parasite and liver cancer (cholangiocarcinoma). METHODS: Chine Hamster Ovary (CHO) cells were treated with F. hepatica extracts and cell proliferation was assessed by using the indirect method for estimating cell number based on the mitochondrial activity with MTS cell proliferation reagent. We observed unexpected death of these cells when treated with F. hepatica extracts. RESULTS: We now hypothesize that this parasite could be used as a medically-important trematode pathogen in cancer therapy.
Entities:
Keywords:
C. sinensis; Chine Hamster Ovary (CHO); Fasciola hepatica; O. viverrini; cholangiocarcinoma; mammalian cells
Authors: Mónica Botelho; António Carlos Ferreira; Maria José Oliveira; Afonso Domingues; José Carlos Machado; José Manuel Correia da Costa Journal: Int J Parasitol Date: 2009-03-12 Impact factor: 3.981
Authors: Mónica C Botelho; Nuno Vale; Maria João Gouveia; Gabriel Rinaldi; Julio Santos; Lucio L Santos; Paula Gomes; Paul J Brindley; José Manuel Correia da Costa Journal: Int J Parasitol Date: 2012-12-20 Impact factor: 3.981
Authors: Andres Garcia-Campos; Carolina N Correia; Amalia Naranjo-Lucena; Laura Garza-Cuartero; Gabriella Farries; John A Browne; David E MacHugh; Grace Mulcahy Journal: Front Immunol Date: 2019-08-29 Impact factor: 7.561